# FDA Inspection 1163624 - Octapharma Plasma Inc - March 04, 2022

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/a5baeda2-9b28-4e0b-80de-ed02fad29a7c
Source feed: FDA_Inspections

> FDA Inspection 1163624 for Octapharma Plasma Inc on March 04, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1163624
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2022-03-04
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1163624 - 2022-03-04](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/6f0b1842-bc32-4f70-849e-5fea256b5c32)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/5cf0a066-441d-4539-9073-18478c9f17b5

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d